These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 24978907)
21. Differentially cleaving peptides as a strategy for controlled drug release in human retinal pigment epithelial cells. Bhattacharya M; Sarkhel S; Peltoniemi J; Broadbridge R; Tuomainen M; Auriola S; Urtti A J Control Release; 2017 Apr; 251():37-48. PubMed ID: 28213274 [TBL] [Abstract][Full Text] [Related]
22. Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study. Fialho SL; Behar-Cohen F; Silva-Cunha A Eur J Pharm Biopharm; 2008 Mar; 68(3):637-46. PubMed ID: 17851057 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant. Park J; Bungay PM; Lutz RJ; Augsburger JJ; Millard RW; Sinha Roy A; Banerjee RK J Control Release; 2005 Jul; 105(3):279-95. PubMed ID: 15896868 [TBL] [Abstract][Full Text] [Related]
24. Controlled release strategy designed for intravitreal protein delivery to the retina. Delplace V; Ortin-Martinez A; Tsai ELS; Amin AN; Wallace V; Shoichet MS J Control Release; 2019 Jan; 293():10-20. PubMed ID: 30419267 [TBL] [Abstract][Full Text] [Related]
25. A new vitreal drug delivery system using an implantable biodegradable polymeric device. Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476 [TBL] [Abstract][Full Text] [Related]
26. ATP-induced relaxation of porcine retinal arterioles depends on the perivascular retinal tissue and acts via an adenosine receptor. Holmgaard K; Aalkjaer C; Lambert JD; Bek T Curr Eye Res; 2007 Apr; 32(4):353-9. PubMed ID: 17453957 [TBL] [Abstract][Full Text] [Related]
27. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection. Huang D; Chen YS; Thakur SS; Rupenthal ID Eur J Pharm Biopharm; 2017 Oct; 119():125-136. PubMed ID: 28602870 [TBL] [Abstract][Full Text] [Related]
28. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. López-Cortés LF; Pastor-Ramos MT; Ruiz-Valderas R; Cordero E; Uceda-Montañés A; Claro-Cala CM; Lucero-Muñoz MJ Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1024-8. PubMed ID: 11274081 [TBL] [Abstract][Full Text] [Related]
29. [Potential of liposomes for the intravitreal injection of therapeutic molecules]. Bochot A; Lajavardi L; Camelo S; Bourges JL; Behar-Cohen F; de Kozak Y; Fattal E Ann Pharm Fr; 2011 Mar; 69(2):100-7. PubMed ID: 21440102 [TBL] [Abstract][Full Text] [Related]
30. Sustaining Intravitreal Residence With L-Arginine Peptide-Conjugated Nanocarriers. Li H; Liu W; Sorenson CM; Sheibani N; Albert DM; Senanayake T; Vinogradov S; Henkin J; Zhang HF Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5142-5150. PubMed ID: 28986592 [TBL] [Abstract][Full Text] [Related]
31. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Koo H; Moon H; Han H; Na JH; Huh MS; Park JH; Woo SJ; Park KH; Kwon IC; Kim K; Kim H Biomaterials; 2012 Apr; 33(12):3485-93. PubMed ID: 22322197 [TBL] [Abstract][Full Text] [Related]
32. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826 [TBL] [Abstract][Full Text] [Related]
34. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon. Hou H; Nieto A; Ma F; Freeman WR; Sailor MJ; Cheng L J Control Release; 2014 Mar; 178():46-54. PubMed ID: 24424270 [TBL] [Abstract][Full Text] [Related]
35. Dilation of porcine retinal arterioles to cilostazol: roles of eNOS phosphorylation via cAMP/protein kinase A and AMP-activated protein kinase and potassium channels. Tanano I; Nagaoka T; Omae T; Ishibazawa A; Kamiya T; Ono S; Yoshida A Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1443-9. PubMed ID: 23341020 [TBL] [Abstract][Full Text] [Related]
36. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy. Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806 [TBL] [Abstract][Full Text] [Related]
37. Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS. Bisht R; Mandal A; Rupenthal ID; Mitra AK Drug Deliv Transl Res; 2016 Dec; 6(6):763-770. PubMed ID: 27371395 [TBL] [Abstract][Full Text] [Related]
38. Self-assembled phenylalanine-α,β-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor. Panda JJ; Yandrapu S; Kadam RS; Chauhan VS; Kompella UB J Control Release; 2013 Dec; 172(3):1151-60. PubMed ID: 24075925 [TBL] [Abstract][Full Text] [Related]
39. Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats. Mori F; King GL; Clermont AC; Bursell DK; Bursell SE Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3955-62. PubMed ID: 11053299 [TBL] [Abstract][Full Text] [Related]
40. In Vivo Retinal Vein Bypass Surgery in a Porcine Model. Shen LJ; Chen YQ; Cheng D; Zhang C; Jiang L; Hong M; Kang QY Curr Eye Res; 2016; 41(1):79-87. PubMed ID: 25549290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]